| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/03/2012 | US8088373 Autocrine growth factor receptor antibodies and methods |
| 01/03/2012 | US8088357 Tumor-specific recognition molecules |
| 01/03/2012 | CA2576715C Modified hiv-1 peptides and use thereof in the detection of anti-hiv antibodies |
| 01/03/2012 | CA2539816C Antigens for an east coast fever vaccine |
| 01/03/2012 | CA2498800C Sqs gene |
| 01/03/2012 | CA2497384C Dna mutagenesis by random fragmentation and reassembly |
| 01/03/2012 | CA2475604C An herpes simplex virus complex |
| 01/03/2012 | CA2457636C Antigen binding domains |
| 01/03/2012 | CA2436049C A serpin in bifidobacteria |
| 01/03/2012 | CA2413258C Interferon-like protein zcyto21 |
| 01/03/2012 | CA2404108C A method of preparing vaccines |
| 01/03/2012 | CA2378574C Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-cd20 antibody |
| 01/03/2012 | CA2366433C Staphylococcus antigen and vaccine |
| 01/03/2012 | CA2348698C Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| 01/03/2012 | CA2266332C Antibodies against human parathyroid hormone related protein |
| 01/03/2012 | CA2258348C Screening compounds for the ability to alter the production of amyloid-.beta. peptide (x-.gtoreq.41) |
| 01/03/2012 | CA2248893C Graphitic nanotubes in luminescence assays |
| 01/03/2012 | CA2242414C Anti-cd18 antibodies for use against stroke |
| 01/03/2012 | CA2227265C Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis |
| 01/03/2012 | CA2226973C Modulators of the function of fas receptors and other proteins |
| 01/03/2012 | CA2224468C P53 protein variants and therapeutical uses thereof |
| 01/03/2012 | CA2215483C Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same |
| 01/03/2012 | CA2178482C Thrombopoietin |
| 01/02/2012 | DE202011103324U1 Therapeutische anti-TIRC7 Antikörper für die Verwendung in Immun und anderen Krankheiten Therapeutic anti-TIRC7 antibodies for use in immune and other diseases |
| 12/29/2011 | WO2011163478A2 Dual variable domain immunoglobulins and uses thereof |
| 12/29/2011 | WO2011163412A1 Antibodies to the c3d fragment of complement component 3 |
| 12/29/2011 | WO2011163314A1 Hybrid light chain mice |
| 12/29/2011 | WO2011163311A1 Mice expressing alight chain with human lambda variable and mouse constant regions |
| 12/29/2011 | WO2011162210A1 Method for purifying protein using amino acid |
| 12/29/2011 | WO2011161970A1 Anti-pdgf receptor antibody |
| 12/29/2011 | WO2011161457A1 Cancer treatment |
| 12/29/2011 | WO2011161430A1 Assay for detecting frre light chains by capillary zone electrophoresis |
| 12/29/2011 | WO2011161266A1 Improved immunoglobulin single variable domains and constructs thereof directed against cxcr4 |
| 12/29/2011 | WO2011161263A1 Pharmaceutical compositions for cutaneous administration |
| 12/29/2011 | WO2011161244A1 Homodimeric protein constructs |
| 12/29/2011 | WO2011161226A2 Novel antibody formulation |
| 12/29/2011 | WO2011161189A1 Anti-hepsin antibodies and methods of use |
| 12/29/2011 | WO2011161119A1 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 12/29/2011 | WO2011161107A1 Small-pool fractionation of immunoglobulin g using caprylic acid and disposable equipment |
| 12/29/2011 | WO2011160859A1 Antibody derivatives |
| 12/29/2011 | WO2011138557A3 Use of an anti-cd71 antibody for preparing a medicament |
| 12/29/2011 | WO2011131746A3 Heterodimeric antibody fc-containing proteins and methods for production thereof |
| 12/29/2011 | WO2011131659A3 Binding domains |
| 12/29/2011 | WO2011121576A3 Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae |
| 12/29/2011 | WO2011097500A3 The tweak/fn14 system regulates skeletal muscle atrophy and regeneration |
| 12/29/2011 | WO2011096698A3 Composition for cancer prognosis prediction comprising anti-tmap/ckap2 antibodies |
| 12/29/2011 | WO2010109165A8 Soluble "heavy-chain only " antibodies |
| 12/29/2011 | US20110321197 Plants with Increased Yield (NUE) |
| 12/29/2011 | US20110319600 Human Anti-Human Influenza Virus Antibody |
| 12/29/2011 | US20110319599 MN Gene and Protein |
| 12/29/2011 | US20110319597 Variant domain antibodies |
| 12/29/2011 | US20110319592 Process for the Purification of Antibodies Using Affinity Resins Comprising Specific Ligands |
| 12/29/2011 | US20110319590 Tumour Cell Lines and Uses Thereof |
| 12/29/2011 | US20110319333 Method and compositions for the treatment and detection of endothelin-1 related kidney diseases |
| 12/29/2011 | US20110319327 Polypeptides Homologous to VEGF and BMP1 |
| 12/29/2011 | US20110319292 Methods for generating anti-il-23 antibodies, compositions, methods and uses |
| 12/29/2011 | US20110319287 Modulator assay |
| 12/29/2011 | US20110319274 Identification of Compounds Modifying a Cellular Response |
| 12/29/2011 | US20110318834 Multiple-tumor aberrant growth genes |
| 12/29/2011 | US20110318832 Human Telomerase Catalytic Subunit |
| 12/29/2011 | US20110318826 Inotropic antibodies and therapeutic uses thereof |
| 12/29/2011 | US20110318809 Method of screening placental proteins responsible for pathophysiology of preeclampsia, and marker for early diagnosis and prediction of preeclampsia |
| 12/29/2011 | US20110318788 Multisignal labeling reagents and processes and uses therefor |
| 12/29/2011 | US20110318766 Arginine vasopressin pro-hormone as predictive biomarker for diabetes |
| 12/29/2011 | US20110318764 Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases |
| 12/29/2011 | US20110318761 Methods and kits for predicting a response to an erythropoietic agent |
| 12/29/2011 | US20110318759 Method for assaying keratan sulfate, assay kit therefor and method for detecting joint disease by using the same |
| 12/29/2011 | US20110318758 Human monoclonal antibodies and methods for producing the same |
| 12/29/2011 | US20110318757 Recombinant anti-muc1 antibodies |
| 12/29/2011 | US20110318749 Method for identifying regulatory t cells |
| 12/29/2011 | US20110318377 Methylated TAT Polypeptides and Methods of Use Thereof |
| 12/29/2011 | US20110318371 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 12/29/2011 | US20110318369 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| 12/29/2011 | US20110318368 Anti-human alpha9 integrin antibody and use thereof |
| 12/29/2011 | US20110318367 Novel targets for treatment of hypercholesterolemia |
| 12/29/2011 | US20110318366 Biologic compounds |
| 12/29/2011 | US20110318363 Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity |
| 12/29/2011 | US20110318362 Novel card proteins involved in cell death regulation |
| 12/29/2011 | US20110318361 Anticancer Drug Comprising Inhibitor of Tmprss4 |
| 12/29/2011 | US20110318357 Methods and compositions based on shiga toxin type 2 protein |
| 12/29/2011 | US20110318356 Antibodies Against Tissue Factor Pathway Inhibitor |
| 12/29/2011 | US20110318355 Mutant proteins of the f protein of piv-5 and piv-2 |
| 12/29/2011 | US20110318354 Cytokine receptor zcytor17 multimers |
| 12/29/2011 | US20110318353 Humanized IL-25 Antibodies |
| 12/29/2011 | US20110318352 Compositions and methods for the treatment of viral infections |
| 12/29/2011 | US20110318350 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 12/29/2011 | US20110318349 Dual variable domain immunoglobulins and uses thereof |
| 12/29/2011 | US20110318347 Amino acid sequences targeting human cd4, cxcr4, ccr5, tlr4, alphav integrin, beta3-integrin, beta1-integrin, human alpha2-integrin, cd81, sr-bi, claudin-1, claudin-6 and claudin-9, respectively, and neutralizing viral entry |
| 12/29/2011 | US20110318345 Nasal delivery |
| 12/29/2011 | US20110318344 Tumor Treatment |
| 12/29/2011 | US20110318343 Stable Liquid Pharmaceutical Formulation Of IgG Antibodies |
| 12/29/2011 | US20110318340 Deglycosylated antibodies |
| 12/29/2011 | US20110318339 Anti-dll4 antibodies and uses thereof |
| 12/29/2011 | US20110318301 Il-17a/f heterologous polypeptides and therapeutic uses thereof |
| 12/29/2011 | US20110318269 Method For Screening Phage Display Libraries Against Each Other |
| 12/29/2011 | US20110318264 Methods and compositions for diagnosis and treatment of cancer |
| 12/29/2011 | CA2804311A1 Mice expressing alight chain with human lambda variable and mouse constant regions |
| 12/29/2011 | CA2803864A1 Mice expressing an immunoglobulin hybrid light chain |
| 12/29/2011 | CA2803588A1 Antibodies to the c3d fragment of complement component 3 |
| 12/29/2011 | CA2803392A1 Dual variable domain immunoglobulins and uses thereof |